{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:08:23Z","timestamp":1789513703780,"version":"build-2803163510"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":90,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.trre.2021.100670","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T22:19:49Z","timestamp":1634854789000},"page":"100670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Review of Standardized Incidence Ratios (SIR) of non-lymphoid de novo malignancies after liver transplantation: Structured analysis of global differences"],"prefix":"10.1016","volume":"36","author":[{"given":"Jay A.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Daoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashokkumar","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2021.100670_bb0005","volume":"4","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.trre.2021.100670_bb0010","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00000658-198410000-00013","article-title":"Venous bypass in clinical liver transplantation","volume":"200","author":"Shaw","year":"1984","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2021.100670_bb0015","first-page":"405","article-title":"Long-term results of orthotopic liver transplantation during the cyclosporin era. 393 orthotopic liver transplantations accomplished in 313 consecutive patients at the Pittsburgh Transplantation Center","volume":"56","author":"Lerut","year":"1989","journal-title":"Helv Chir Acta"},{"key":"10.1016\/j.trre.2021.100670_bb0020","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/jlts.2001.25364","article-title":"Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years","volume":"7","author":"Jain","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2021.100670_bb0025","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000658-200010000-00004","article-title":"Long-term survival after liver transplantation in 4,000 consecutive patients at a single center","volume":"232","author":"Jain","year":"2000","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2021.100670_bb0030","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.transproceed.2009.03.079","article-title":"De novo tumors are a major cause of late mortality after orthotopic liver transplantation","volume":"41","author":"Baccarani","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100670_bb0035","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1053\/jlts.2001.28645","article-title":"B. De novo malignancies after liver transplantation: a major cause of late death","volume":"7","author":"Fung","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2021.100670_bb0040","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.transproceed.2006.07.029","article-title":"Late mortality in 679 consecutive liver transplant recipients: the Gothenburg liver transplant experience","volume":"38","author":"Lukes","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100670_bb0045","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00000658-196809000-00010","article-title":"discussion of Murray JE Tea. Five years experience in renal transplanation with immunosuppressive drugs; srvival, function, complication, and role of lymphocyte depletion by thoracic duct fistula","volume":"168","author":"Stazl","year":"1968","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2021.100670_bb0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00007890-196908000-00033","article-title":"Primary malignancy in patients undergoing immunosuppression for renal transplantation","volume":"8","author":"McKhann","year":"1969","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100670_bb0055","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00007890-197210000-00001","article-title":"Malignant tumors arising de novo in immunosuppressed organ transplant recipients","volume":"14","author":"Penn","year":"1972","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100670_bb0060","article-title":"The Israel Penn international transplant tumor registry","volume":"1053","author":"Witherow","year":"2003","journal-title":"AMIA Annu Symp Proc"},{"key":"10.1016\/j.trre.2021.100670_bb0065","first-page":"1247","article-title":"Malignancy following liver transplantation: a report from the Australian Combined Liver Transplant Registry","volume":"27","author":"Sheil","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100670_bb0070","first-page":"1397","article-title":"De novo malignancy following liver transplantation: a single-center study","volume":"25","author":"Levy","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100670_bb0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/lt.500020109","article-title":"Posttransplantation de novo tumors in liver allograft recipients","volume":"2","author":"Penn","year":"1996","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.trre.2021.100670_bb0080","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1600-6143.2004.00380.x","article-title":"De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years?","volume":"4","author":"Benlloch","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100670_bb0085","first-page":"1172","article-title":"Non-lymphoid cancer after liver transplantation","volume":"44","author":"Frezza","year":"1997","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.trre.2021.100670_bb0090","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/S0041-1345(03)00641-9","article-title":"Upper aerodigestive tract and lung tumors after liver transplantation","volume":"35","author":"Jimenez","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100670_bb0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0041-1345(01)02770-1","article-title":"De novo tumors after orthotopic liver transplantation","volume":"34","author":"Jimenez","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100670_bb0100","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/(SICI)1097-0142(19970915)80:6<1141::AID-CNCR18>3.0.CO;2-8","article-title":"De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin","volume":"80","author":"Jonas","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.trre.2021.100670_bb0105","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1237::AID-CNCR25>3.0.CO;2-5","article-title":"Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors","volume":"83","author":"Kelly","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.trre.2021.100670_bb0110","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.transproceed.2012.01.027","article-title":"De novo malignancies after liver transplantation: incidence comparison with the Korean cancer registry","volume":"44","author":"Park","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100670_bb0115","first-page":"106","article-title":"Malignant lymphomas in transplantation patients","volume":"1","author":"Penn","year":"1969","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100670_bb0120","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/jlts.2002.32977","article-title":"Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation","volume":"8","author":"Saigal","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2021.100670_bb0125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/jlts.2002.29350","article-title":"De novo tumors after liver transplantation: a single-institution experience","volume":"8","author":"Sanchez","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2021.100670_bb0130","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s12072-010-9231-1","article-title":"Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre","volume":"5","author":"Sapisochin","year":"2011","journal-title":"Hepatol Int"},{"key":"10.1016\/j.trre.2021.100670_bb0135","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1399-0012.2006.00527.x","article-title":"De novo malignancies following liver transplantation: a case-control study with long-term follow-up","volume":"20","author":"Yao","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2021.100670_bb0140","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/00007890-199811150-00014","article-title":"Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data","volume":"66","author":"Jain","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100670_bb0145","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/lt.21475","article-title":"Risk of malignant neoplasms after liver transplantation: a population-based study","volume":"14","author":"Aberg","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2021.100670_bb0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.dld.2009.04.017","article-title":"Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries","volume":"42","author":"Baccarani","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.trre.2021.100670_bb0155","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/liv.12758","article-title":"Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors","volume":"35","author":"Carenco","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.trre.2021.100670_bb0160","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/ctr.12171","article-title":"De novo malignancy post-liver transplantation: a single center, population controlled study","volume":"27","author":"Chatrath","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2021.100670_bb0165","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/j.1600-6143.2010.03181.x","article-title":"Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit","volume":"10","author":"Collett","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100670_bb0170","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1016\/j.transproceed.2013.07.050","article-title":"De novo malignancies following liver transplantation: results from a multicentric study in central and southern Italy, 1990-2008","volume":"45","author":"Ettorre","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100670_bb0175","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1111\/j.1600-6143.2009.02766.x","article-title":"Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients","volume":"9","author":"Finkenstedt","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100670_bb0180","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0168-8278(00)00077-5","article-title":"Increased cancer risk after liver transplantation: a population-based study","volume":"34","author":"Haagsma","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.trre.2021.100670_bb0185","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000310","article-title":"Post-transplant malignancy in liver transplantation: a single center experience","volume":"93","author":"Hsiao","year":"2014","journal-title":"Med (Baltim)"},{"key":"10.1016\/j.trre.2021.100670_bb0190","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/lt.21554","article-title":"Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study","volume":"14","author":"Jiang","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2021.100670_bb0195","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/TP.0b013e318288ca83","article-title":"De novo malignancies after adult-to-adult living-donor liver transplantation with a malignancy surveillance program: comparison with a Japanese population-based study","volume":"95","author":"Kaneko","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100670_bb0200","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/ijc.27765","article-title":"Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study","volume":"132","author":"Krynitz","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trre.2021.100670_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065238","article-title":"Early and late de novo tumors after liver transplantation in adults: the late onset of bladder tumors in men","volume":"8","author":"Maggi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.trre.2021.100670_bb0210","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/ajt.14507","article-title":"Decreasing incidence of cancer after liver transplantation-A Nordic population-based study over 3 decades","volume":"18","author":"Nordin","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100670_bb0215","article-title":"Post-transplant malignancy in solid organ transplant recipients in Ireland, The Irish Transplant Cancer Group","volume":"33","author":"O\u2019Neill","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2021.100670_bb0220","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/01.TP.0000173775.16579.18","article-title":"Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales","volume":"80","author":"Oo","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100670_bb0225","doi-asserted-by":"crossref","first-page":"17202","DOI":"10.1038\/s41598-019-53163-9","article-title":"De novo cancer incidence after kidney and liver transplantation: Results from a nationwide population based data","volume":"9","author":"Park","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.trre.2021.100670_bb0230","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/lt.24795","article-title":"The 28-year incidence of de novo malignancies after liver transplantation: A single-center analysis of risk factors and mortality in 1616 patients","volume":"23","author":"Rademacher","year":"2017","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2021.100670_bb0235","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/lt.23722","article-title":"Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection","volume":"19","author":"Schrem","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2021.100670_bb0240","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/lt.25310","article-title":"Longterm risk of solid organ De Novo malignancies after liver transplantation: A french national study on 11,226 patients","volume":"24","author":"Seree","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2021.100670_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.31552","article-title":"Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985-2014","author":"Taborelli","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trre.2021.100670_bb0250","doi-asserted-by":"crossref","first-page":"36685","DOI":"10.18632\/oncotarget.13124","article-title":"De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population study","volume":"8","author":"Tsai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.trre.2021.100670_bb0255","doi-asserted-by":"crossref","first-page":"224","DOI":"10.6002\/ect.2019.0210","article-title":"De Novo Malignancy after heart, kidney, and liver transplant: a nationwide study in Taiwan","volume":"18","author":"Yeh","year":"2020","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.trre.2021.100670_bb0260","article-title":"Spectrum of De Novo cancers and predictors in liver transplantation: analysis of the scientific registry of transplant recipients database","volume":"11","author":"Zhou","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.trre.2021.100670_bb0265","series-title":"The surveillance E, and end results (SEER)","year":"2021"},{"key":"10.1016\/j.trre.2021.100670_bb0270","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/lt.21609","article-title":"Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow-up","volume":"14","author":"Jain","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2021.100670_bb0275","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/jlts.2001.28744","article-title":"Risk factors for development of de novo neoplasia after liver transplantation","volume":"7","author":"Xiol","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2021.100670_bb0280","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000658-200210000-00005","article-title":"Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience","volume":"236","author":"Jain","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2021.100670_bb0285","series-title":"P E. Discussion of cellular and humoral aspects of hypersensitive states","first-page":"273","volume":"5","year":"1909"},{"key":"10.1016\/j.trre.2021.100670_bb0290","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.18632\/oncotarget.12739","article-title":"The concept of immune surveillance against tumors. The first theories","volume":"8","author":"Ribatti","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.trre.2021.100670_bb0295","series-title":"Cellular and humoral aspects of the hypersensitive states, \u201cHoeber-Harper, New Yor.\u201d \u201cHoeber-Harper, New York\u201d Google search","first-page":"529","author":"Thomas","year":"1959"},{"key":"10.1016\/j.trre.2021.100670_bb0300","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trre.2021.100670_bb0305","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1158\/0008-5472.CAN-05-4603","article-title":"The DNA damage response arouses the immune system","volume":"66","author":"Gasser","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.trre.2021.100670_bb0310","first-page":"241","article-title":"Depressed immunity and the development of cancer","volume":"18","author":"Penn","year":"1994","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.trre.2021.100670_bb0315","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/MOT.0000000000000069","article-title":"Liver transplantation: immunosuppression and oncology","volume":"19","author":"Rodriguez-Peralvarez","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.trre.2021.100670_bb0320","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/0886022X.2020.1785499","article-title":"The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients","volume":"42","author":"Murray","year":"2020","journal-title":"Ren Fail"},{"key":"10.1016\/j.trre.2021.100670_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194975","article-title":"Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months","volume":"13","author":"Wolf","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.trre.2021.100670_bb0330","doi-asserted-by":"crossref","first-page":"845438","DOI":"10.1155\/2014\/845438","article-title":"The role of mTOR inhibitors in liver transplantation: reviewing the evidence","volume":"2014","author":"Klintmalm","year":"2014","journal-title":"J Transplant"},{"key":"10.1016\/j.trre.2021.100670_bb0335","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.transproceed.2009.03.055","article-title":"Alcohol abuse and de novo tumors in liver transplantation","volume":"41","author":"Zanus","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100670_bb0340","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.transproceed.2009.05.012","article-title":"Causes and predisposing factors of de novo tumors in our series of liver transplant recipients","volume":"41","author":"Tallon Aguilar","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100670_bb0345","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/lt.21722","article-title":"Smoking behavior in liver transplant recipients","volume":"15","author":"van der Heide","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2021.100670_bb0350","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1186\/1471-2407-14-776","article-title":"Increased incidence of head and neck cancer in liver transplant recipients: a meta-analysis","volume":"14","author":"Liu","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.trre.2021.100670_bb0355","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJM199712113372401","article-title":"Alcohol consumption and mortality among middle-aged and elderly U.S. adults","volume":"337","author":"Thun","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2021.100670_bb0360","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.1971.03190170031005","article-title":"Cigarette smoking and cancer of the mouth, pharynx, and larynx. A continuing study","volume":"218","author":"Moore","year":"1971","journal-title":"JAMA"},{"key":"10.1016\/j.trre.2021.100670_bb0365","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.jtho.2016.05.021","article-title":"The international epidemiology of lung cancer: latest trends, disparities, and tumor characteristics","volume":"11","author":"Cheng","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.trre.2021.100670_bb0370","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/00007890-200011150-00012","article-title":"Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus","volume":"70","author":"Jain","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100670_bb0375","first-page":"2883","article-title":"Upper respiratory and digestive tract malignancies after liver transplantation for alcoholic cirrhosis","volume":"28","author":"Duvoux","year":"1996","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100670_bb0380","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00007890-199902150-00014","article-title":"Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis","volume":"67","author":"Duvoux","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100670_bb0385","series-title":"Disease recurence after liver transplantation","volume":"2016","year":"2016"},{"key":"10.1016\/j.trre.2021.100670_bb0390","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/gast.1996.v110.pm8566577","article-title":"Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"110","author":"Brentnall","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trre.2021.100670_bb0395","first-page":"1285","article-title":"The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis","volume":"92","author":"Marchesa","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.trre.2021.100670_bb0400","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/BF02050624","article-title":"Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease","volume":"36","author":"Bleday","year":"1993","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.trre.2021.100670_bb0405","first-page":"260","article-title":"Incidence and management of colorectal cancer in liver transplant recipients","volume":"7","author":"Nishihori","year":"2008","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.trre.2021.100670_bb0410","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1600-6143.2010.03049.x","article-title":"Risk of colorectal carcinoma in post-liver transplant patients: a systematic review and meta-analysis","volume":"10","author":"Sint Nicolaas","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100670_bb0415","first-page":"120","article-title":"Immunosuppression in patients with Barrett\u2019s esophagus: one piece of the puzzle?","volume":"112","author":"Kaiser","year":"1992","journal-title":"Surgery"},{"key":"10.1016\/j.trre.2021.100670_bb0420","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/00365529609006420","article-title":"Esophageal malignancy after liver transplantation in a patient with Barrett\u2019s esophagus","volume":"31","author":"Ilan","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.trre.2021.100670_bb0425","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/lt.500050405","article-title":"Rapid progression to high-grade dysplasia in Barrett\u2019s esophagus after liver transplantation","volume":"5","author":"Trotter","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.trre.2021.100670_bb0430","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1432-2277.2003.tb00363.x","article-title":"Rapid development of esophageal squamous cell carcinoma after liver transplantation for alcohol-induced cirrhosis","volume":"16","author":"Kenngott","year":"2003","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2021.100670_bb0435","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/lt.21058","article-title":"De novo esophageal neoplasia after liver transplantation","volume":"13","author":"Presser","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2021.100670_bb0440","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/oxfordjournals.aje.a009440","article-title":"Kaposi\u2019s sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology","volume":"147","author":"Moore","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.trre.2021.100670_bb0445","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/00007890-199804270-00025","article-title":"Kaposi\u2019s sarcoma in liver transplant recipients on FK506","volume":"65","author":"Kadry","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100670_bb0450","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/030089169508100502","article-title":"Epidemiology of classic Kaposi\u2019s sarcoma, with special reference to mediterranean population","volume":"81","author":"Franceschi","year":"1995","journal-title":"Tumori"},{"key":"10.1016\/j.trre.2021.100670_bb0455","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1158\/1055-9965.EPI-08-0671","article-title":"Risk factors for classical Kaposi sarcoma in a population-based case-control study in Sicily","volume":"17","author":"Anderson","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.trre.2021.100670_bb0460","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MOT.0000000000000499","article-title":"Long-term care of transplant recipients: de novo neoplasms after liver transplantation","volume":"23","author":"Burra","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.trre.2021.100670_bb0465","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.mcna.2016.01.006","article-title":"De Novo Malignancies after transplantation: risk and surveillance strategies","volume":"100","author":"Doycheva","year":"2016","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.trre.2021.100670_bb0470","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/lt.23566","article-title":"Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"19","author":"Lucey","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2021.100670_bb0475","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00004836-200305000-00016","article-title":"Malignancy after liver transplantation in patients with premalignant conditions","volume":"36","author":"Menachem","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.trre.2021.100670_bb0480","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/gut.2005.080358","article-title":"Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients","volume":"55","author":"Naylor","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.trre.2021.100670_bb0485","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00007890-199701270-00012","article-title":"Weaning of immunosuppression in liver transplant recipients","volume":"63","author":"Mazariegos","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100670_bb0490","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/ajt.15205","article-title":"Outcomes of immunosuppression minimization and withdrawal early after liver transplantation","volume":"19","author":"Shaked","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100670_bb0495","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1586\/14737159.2016.1139455","article-title":"Profile of the Pleximmune blood test for transplant rejection risk prediction","volume":"16","author":"Sindhi","year":"2016","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.trre.2021.100670_bb0500","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/978-1-62703-493-7_21","article-title":"Cylex immuknow cell function assay","volume":"1034","author":"Zeevi","year":"2013","journal-title":"Methods Mol Biol"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X21000768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X21000768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T16:06:42Z","timestamp":1760630802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X21000768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0955470X21000768"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2021.100670","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of Standardized Incidence Ratios (SIR) of non-lymphoid de novo malignancies after liver transplantation: Structured analysis of global differences","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2021.100670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100670"}}